uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
HemAryo
Application withdrawn
Human
Details
EMA number
EMEA/H/C/005547
ATC code
B02BD08
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of bleeding episodes and for the prevention of bleeding.
MeSH:
Hemophilia A;Hemophilia B;Factor VII Deficiency
Group:
Antihemorrhagics
Active substances
eptacog alfa (activated)
Marketing Authorisation Holder
UGA Biopharma
MAH
HemAryo | uMedical